Anti-tumor efficacy of a bevacizumab preconditioning followed by etoposide and cisplatin regimen in human epidermal growth factor receptor-2-positive breast cancer brain metastasis refractory to whole brain radiotherapy-Reference-Cited by-同舟云学术

Anti-tumor efficacy of a bevacizumab preconditioning followed by etoposide and cisplatin regimen in human epidermal growth factor receptor-2-positive breast cancer brain metastasis refractory to whole brain radiotherapy

Published:2023 Issue:1 Volume:10 Page:11
ISSN:2311-3006
Container-title:Journal of Cancer Research and Practice
language:en
Short-container-title:J Cancer Res Pract

Author:

Lu Yen-Shen,Chen TomWei-Wu,Lin Ching-Hung,Yeh Dah-Cherng,Tseng Ling-Ming,Rau Kun-Ming,Chen Bang-Bin,Chao Ta-Chung,Huang Shu-Min,Chang Dwan-Ying,Chen I-Chun,Cheng Ann-Lii

Publisher

Medknow

Subject

General Medicine

Reference38 articles.

1. Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American society of clinical oncology clinical practice guideline;Ramakrishna;J Clin Oncol,2014

2. Central nervous system involvement in breast cancer patients: Is the therapeutic landscape changing too slowly?;Fontanella;Cancer Treat Rev,2016

3. Brain metastases after breast-conserving therapy and systemic therapy: Incidence and characteristics by biologic subtype;Arvold;Breast Cancer Res Treat,2012

4. Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes;Thomson;Br J Cancer,2016

5. Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases;Lin;J Neurooncol,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corrigendum: Anti-tumor Efficacy of a Bevacizumab Preconditioning followed by Etoposide and Cisplatin Regimen in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer Brain Metastasis Refractory to Whole Brain Radiotherapy;Journal of Cancer Research and Practice;2024-04